Senior Director, CMH Communications

At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen how health is understood and managed, and support the communities we serve. This is hard, urgent, selfless work—but it’s work worth doing. If you’re driven by purpose and ready to bring your best to work that truly matters for patients, we invite you to join us.  The Senior Director leads external communications for Lilly's on-market cardiometabolic medicines — currently Mounjaro (tirzepatide for type 2 diabetes), Zepbound (tirzepatide for obesity), and Foundayo (orforglipron for obesity) — as well as new indications and label expansions as they are approved. This role owns the consumer obesity communications strategy, which is a defining capability of the CMH Communications team, and leads global communications for all approved products, including coordination with international affiliates across 40+ markets. This is a high-visibility, high-velocity role that requires both strategic vision and the ability to move fast. The Senior Director must be as comfortable shaping a long-term consumer narrative as they are managing an emerging media issue — and must actively contribute across the broader CMH Communications team as priorities shift.

ON-MARKET BRAND COMMUNICATIONS • Own the external communications strategy for all approved CMH products, including earned media, thought leadership, advocacy partnerships, and consumer campaigns. • Lead consumer obesity communications and develop innovative integrated campaigns that engage diverse audiences. • Develop and maintain brand narratives for Mounjaro, Zepbound, and Foundayo, ensuring consistency across all channels and geographies. • Support new indication launches and label expansions as they come through regulatory review, owning the communications strategy from pre-approval in partnership with Scientific Innovation team through post-launch. Global communications • Lead the global communications strategy for approved products, ensuring consistent messaging and coordinated execution across international affiliates. • Partner with affiliates to provide materials, messaging frameworks, and strategic guidance — enabling local market execution while maintaining global narrative integrity. • Coordinate with the Scientific Innovation team to ensure smooth handoff of global communications as products move from regulatory approval into commercialization. MEDICAL MEETING COMMUNICATIONS • Lead communications strategy and execution for priority CMH medical meetings — including ADA, EASD, ACC, and AHA — in partnership with Scientific Innovation, and other cross-functional comms partners. • Develop materials including press releases, media backgrounders, data summaries, and HCP-facing content timed to scientific presentations. Issues management & media relations • Anticipate and lead communications challenges related to on-market products — including pricing and access, competitive dynamics, compounding, and safety. • Partner with Issues and Crisis Communications Team and Enterprise Communications to maintain and develop relationships with A-list media; serve as spokesperson and support internal spokespeople with counsel and media preparation. • Oversee on-market PR agency relationships, ensuring high-quality output and strategic alignment. Team & cross-functional collaboration • Operate as an active and flexible member of the broader CMH Communications team and Global Corporate Communications team contributing to pipeline, internal, and enterprise projects as the workload demands. • Partner closely with marketing, medical affairs, regulatory,